Wells Fargo raised the firm’s price target on MetLife (MET) to $97 from $94 and keeps an Overweight rating on the shares ahead of quarterly results. The firm says the focus should be on pricing, loss trend, and reserves for P&C companies, organic and margin for brokers, and sales/VII/capital for life companies.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MET:
- MetLife price target raised to $94 from $88 at Barclays
- Ameriprise price target raised to $434 from $423 at Piper Sandler
- Brighthouse Financial price target lowered to $55 from $63 at Piper Sandler
- MetLife Announces $10 Billion Reinsurance Deal with Chariot
- MetLife sees Q2 variable investment income $175M-$225M pre-tax